Covetrus, Inc.
CVET · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/29/2018 | |
|---|---|---|---|---|
| Revenue | $5 | $4 | $4 | $4 |
| % Growth | 5.4% | 9.1% | 5.2% | – |
| Cost of Goods Sold | $4 | $4 | $3 | $3 |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 18.8% | 18.4% | 18.8% | 18.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $1 | $1 | $1 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Income | -$0 | -$0 | -$1 | $0 |
| % Margin | -0.5% | -1.6% | -25.1% | 3.6% |
| Other Income/Exp. Net | -$0 | $0 | -$0 | $0 |
| Pre-Tax Income | -$0 | -$0 | -$1 | $0 |
| Tax Expense | $0 | -$0 | -$0 | $0 |
| Net Income | -$0 | -$0 | -$1 | $0 |
| % Margin | -1.9% | -0.4% | -25.6% | 2.7% |
| EPS | -0.63 | -0.16 | -9.52 | 0.91 |
| % Growth | -293.7% | 98.3% | -1,146.2% | – |
| EPS Diluted | -0.63 | -0.16 | -9.52 | 0.91 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | -$1 | $0 |
| % Margin | 3.9% | 4.9% | -20% | 5.3% |